BioNTech SE (BNTX) Misses Q3 EPS by 22c; lifts guidance

BioNTech SE (NASDAQ: BNTX) reported Q3 EPS of (EUR0.12), EUR0.22 worse than the analyst estimate of EUR0.10. Revenue for the quarter came in at EUR1.52 billion versus the consensus estimate of EUR1.01 billion.

GUIDANCE:

BioNTech SE sees FY2025 revenue of EUR2.6-2.8 billion, versus the consensus of EUR2.41 billion.

For earnings history and earnings-related data on BioNTech SE (BNTX) click here.

You May Also Be Interested In

• Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
• Bernstein SocGen Group Reiterates Outperform Rating on Hermes International (RMS:FP) (HESAY) after cautious commentary
• Bernstein SocGen Reiterates Outperform Rating on Fervo Energy (FRVO)